ClinicalTrials.Veeva

Menu

Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study

S

Shanghai Pulmonary Hospital, Shanghai, China

Status

Enrolling

Conditions

Lung Cancer
PET-CT

Treatments

Diagnostic Test: PET-CT

Study type

Observational

Funder types

Other

Identifiers

NCT07243873
PETgeneration

Details and patient eligibility

About

This study aims to synthesise PET data that preserves biological relevance and adds clinical value to the diagnosis and prognosis of lung cancer by establishing anatomical-to-metabolic mapping based on paired diagnostic CT and FDG-PET scans, thereby prospectively validating the clinical utility of the model.

Enrollment

10,000 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with non-small cell lung cancer scheduled to undergo PET-CT and pathological examinations;
  2. Voluntarily participate and sign an informed consent form;

Exclusion criteria

  1. History of other malignant tumours;
  2. Image artefacts;
  3. Without pathological diagnostic information;
  4. Without paired CT and FDG-PET scan images.

Trial contacts and locations

5

Loading...

Central trial contact

Xinchen Shen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems